LifeSci Search

On August 31st, we proudly support and raise awareness for International Overdose Awareness Day. This year’s theme, “Together we can,” spotlights the power of collective action in tackling overdose issues. Whether you are affected personally, involved in healthcare, or advocating for change, your role is crucial. Let’s unite our efforts to support those impacted by overdose and advocate for necessary reforms. Learn more: https://lnkd.in/gcZ2xcU #TogetherWeCan #EndOverdose #IOAD2024

We’re pleased to feature LifeSci Consulting, a crucial part of our network. They are experts in global strategy, operations, and transaction advisory, collaborating with enterprises across the #LifeSciences sector to tackle complex challenges. Their objective? To expedite the delivery of transformative treatments to patients. Learn more about their impactful work below.👇 #Consulting #BioTech #Pharma #PrivateEquity

ArriVent Biopharma faced a significant challenge in identifying a VP of Business Development skilled in oncology with a balanced approach to in-licensing and out-licensing. Our search strategy quickly matched them with Matthew Stout, MD, PhD. With his rich background at major pharmaceutical companies and recent focus at smaller biotech firms, Matthew is now poised to effectively lead ArriVent’s business strategies. Discover how we connect biotech firms with top-tier leadership: https://lnkd.in/ehyeFP9e What traits do you consider crucial for leadership in business development within the biotech industry? Share your insights below. #LifeSciences #Oncology #Biotech #BioPharma #ExecutiveRecruitment

Congratulations to Matthew Strout on his appointment as VP of Business Development at ArriVent Biopharma. With a keen focus on accelerating the delivery of innovative therapies globally, ArriVent will benefit from Matthew's vast expertise. Thank you to Zachary Charles, Alexis Darby, and Emily Bravaco from our team for facilitating this strategic appointment. #LifeSciences #GlobalHealth #BusinessDevelopment #ArriVent #CareerAdvancement

We're pleased to announce Ravi Kolla's appointment as Vice President and Head of Corporate Strategy and Partnerships at HelixNano. Emerging from George Church's lab, HelixNano is advancing mRNA technologies to forge new paths in vaccine development. Ravi’s rich background in biotech and strategic alliances across infectious diseases and oncology makes him a stellar fit. Cheers to John Spencer, Eric Simpson, Allison Carney Siegfried, and Perri Roberson from our team for this great find! #LifeSciences #mRNA #VaccineDevelopment #Biotechnology

We congratulate Jeff Hackman on landing his new role as the CEO and Director of Fennec Pharmaceuticals Inc (NASDAQ: FENC). Fennec is a commercial-stage specialty pharmaceutical company with PEDMARK®, the first and only therapy approved in the U.S. and Europe to reduce the risk of permanent damage from cisplatin-induced ototoxicity in pediatric cancer patients. Jeff will guide Fennec’s strategic direction for operational success in the expansion of PEDMARK® use in community oncology and the adolescent and young adult (AYA) population Kudos to our team: Molly Robb, Ayesha Price, Emily Bravaco, and Cari Maguire for guiding this pivotal placement. Read the official press release here: https://lnkd.in/eeUShdZQ #LifeSciences #Oncology #Leadership #PediatricOncology #CommunityOncology #CEOleadership

We're excited to announce Dara Grantham Wright's appointment to the Cleveland Diagnostics, Inc. board of Directors. With a distinguished career in life sciences and clinical diagnostics, Wright's expertise spans leadership roles at Bio-Rad, Thermo Fisher Scientific, and Becton Dickinson. Her strategic vision and commercial success in the industry make her a unique asset to Cleveland Diagnostics and its mission to expand access to leading-edge diagnostic tests. Cleveland Diagnostics is revolutionizing early cancer detection. Their cutting-edge technology aims to enhance diagnosis and treatment across various cancers. Read more about Wright's role and the future of Cleveland Diagnostics here: https://lnkd.in/ed3nBcw8 #BOD #LifeSciences #ExecutiveRecruitment #EarlyDetection

Managing Director Molly Robb provides compelling insights into the ongoing debate about Ph.D. requirements for scientist roles. She highlights that while Ph.D.s add depth to specialized research roles, diverse competencies are crucial for leadership positions. Molly’s perspective sheds light on the varied paths to success in the life sciences sector. Read the full BioSpace article to explore more about the evolving qualifications in science careers: https://lnkd.in/gMe8bbaQ #LifeSciences #ScienceCareers #CareerAdvice

Lung cancer remains the leading cause of cancer-related deaths worldwide, with significant impacts regardless of gender. Advancements in early detection and treatment have improved outcomes, yet awareness and education are crucial. Join us in learning more about prevention, early detection, and the latest treatments available. Take action and inform yourself to help reduce the global burden of this disease. 🔗 Discover more about lung cancer and how you can contribute to prevention efforts: https://lnkd.in/ezE-BTPY #LungCancer #BronchusCancer #CancerPrevention #CancerTherapies

Don't miss Rahil Haneef, our Principal and Senior VP, as he participates in the Nucleate event today at 3pm! Rahil will share his expertise in #biotech VC and entrepreneurship, offering valuable insights for anyone curious about launching a career in this evolving industry. Tune into expert advice and the chance to advance your career. Join us for this informative session! 🔗 Register now: https://lu.ma/y795l12s #LifeSciences #CareerAdvice